Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Traditional Chinese Medicine Holdings Co has the GF Score of 42, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
China Traditional Chinese Medicine Holdings Co (OTCPK:CHIZF) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
China Traditional Chinese Medicine Holdings Co GF Score Related Terms
CHIZF vs ZTS: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Traditional Chinese Medicine Holdings Co GF Score vs Drug Manufacturers Industry
China Traditional Chinese Medicine Holdings Co (CHIZF) has a GF Score of 42 as of Aug. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. This is 48% below median its historical median of 80.00. Over the past decade, China Traditional Chinese Medicine Holdings Co's GF Score has ranged from 43.00 to 100.00.
Is China Traditional Chinese Medicine Holdings Co's GF Score too high?
China Traditional Chinese Medicine Holdings Co's current GF Score of 42 is 48% below median its 10-year median of 80.00. Over the past 10 years, this metric has ranged from a low of 43.00 to a high of 100.00. Overall, China Traditional Chinese Medicine Holdings Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does China Traditional Chinese Medicine Holdings Co's GF Score compare to ZTS?
China Traditional Chinese Medicine Holdings Co's GF Score of 42 can be compared against companies in the Drug Manufacturers industry. Historically, China Traditional Chinese Medicine Holdings Co's own GF Score has ranged from 43.00 to 100.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. China Traditional Chinese Medicine Holdings Co's current GF Score is 42, which is 48% below median its own 10-year median of 80.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Traditional Chinese Medicine Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co (CHIZF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.16 — trading 54.7% below its estimated fair value. The current GF Score is 42, which is 48% below median its 10-year median of 80.00. China Traditional Chinese Medicine Holdings Co's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For China Traditional Chinese Medicine Holdings Co (CHIZF), the current GF Score is 42 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Traditional Chinese Medicine Holdings Co (CHIZF) Overvalued in 2026?
Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co stock appears to be undervalued.
The current stock price of $0.16 is trading 54.7% below its estimated GF Value™ of $0.36.
GuruFocus considers China Traditional Chinese Medicine Holdings Co to be Possible Value Trap.
Key valuation signals for CHIZF:
GF Score: 42 (48% below median its 10-year median of 80.00)
GF Value™: $0.36 vs. price of $0.16 (54.7% below fair value)
No single metric tells the full story. See the CHIZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.
42GF Score
Get the complete analysis for CHIZF
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIZF has been successfully added to your 
